SCHEMBL16266993

SCHEMBL16266993

COc1ccc(C=CC(=O)O)c(C(F)F)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.51
ATM Q13315 1/20 0.51
MAPT P10636 4/20 0.50
ALDH1A1 P00352 2/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
GAA P10253 1/20 0.49
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
JUN P05412 1/20 0.47
NFKB1 P19838 1/20 0.47
TNFRSF1A P19438 1/20 0.46
HDAC8 Q9BY41 1/20 0.44
PTGS2 P35354 1/20 0.44
LY96 Q9Y6Y9 1/20 0.44
ABCG2 Q9UNQ0 1/20 0.43
PTGER4 P35408 1/20 0.43
PTGER3 P43115 1/20 0.43
PTGER2 P43116 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16266990 1.00 THRB (0.51) THRBATMMAPTALDH1A1MEN1
SCHEMBL490210 0.87 THRB (0.53) THRBATMMAPTALDH1A1MEN1
SCHEMBL490211 0.87 THRB (0.53) THRBATMMAPTALDH1A1MEN1
SCHEMBL29046248 0.81 KDM4E (0.47) THRBATMMAPTALDH1A1MEN1
SCHEMBL9559216 0.80 ATM (0.41) THRBATMMAPTALDH1A1MEN1
SCHEMBL30380928 0.80 MIF (0.61) THRBATMMAPTALDH1A1MEN1
SCHEMBL1920579 0.80 MIF (0.61) THRBATMMAPTALDH1A1MEN1
SCHEMBL15239140 0.80 MIF (0.61) THRBATMMAPTALDH1A1MEN1
SCHEMBL1920580 0.80 MIF (0.61) THRBATMMAPTALDH1A1MEN1
SCHEMBL5799211 0.80 THRB (0.46) THRBATMMAPTALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9255071-B2 Compounds having antibacterial activity, process for their preparation and pharmaceutical compositions comprising them CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TÉCNICAS (CONICET) (AR) 2016-02-09 US disclosed
US-20140357678-A1 COMPOUNDS HAVING ANTIBACTERIAL ACTIVITY, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECNICAS (CONICET) (AR) 2014-12-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140357678-A1 COMPOUNDS HAVING ANTIBACTERIAL ACTIVITY, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM C5, CBR3, C1R THRB 1081/4885ATM 4705/4885MAPT 4222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.